The new link between gut-brain axis and neuropsychiatric disorders

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 14, Issue 5, 2011, Pages 477-482

  Fetissov, Sergueï O ^a   Déchelotte, Pierre ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

anorexia nervosa; autoantibodies; bulimia; gut barrier; melanocytestimulating hormone; microflora; nutrition; peptide hormones; psychoneuroimmunology

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN; NEUROPEPTIDE; PROBIOTIC AGENT;

ANXIETY DISORDER; BEHAVIOR; DEPRESSION; EATING DISORDER; EMOTION; HUMAN; HUMORAL IMMUNITY; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; MAJOR DEPRESSION; MOLECULAR MIMICRY; NARCOLEPSY; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; SLEEP DISORDER;

ADAPTIVE IMMUNITY; ANIMALS; BRAIN; DIET; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; IMMUNOGLOBULINS; MENTAL DISORDERS; MOLECULAR MIMICRY; NEUROPEPTIDES;

EID: 80051780284     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32834936e7     Document Type: Review

References (65)

1. Hokfelt T, Bartfai T, Bloom F. Neuropeptides: opportunities for drug discovery. Lancet Neurol 2003;2:463-472. (Pubitemid 36876103)
2. Kastin AJ, Pan W. Concepts for biologically active peptides. Curr Pharm Des 2010;16:3390-3400. The world-leading experts on biologically active peptides present important updates on the concepts underlying actions of neuropeptides and peptide hormones. A particular emphasis is given to explain the action of peripheral peptides on the brain.
3. Warren MP. Endocrine Manifestations of Eating Disorders. J Clin Endocrinol Metab 2011;96:333-343.
4. Alldredge B. Pathogenic involvement of neuropeptides in anxiety and depression. Neuropeptides 2010;44:215-224.
5. Bonnavion P, de Lecea L Hypocretins in the control of sleep and wakefulness. Curr Neurol Neurosci Rep 2010;10:174-179.
6. Scherag S, Hebebrand J, Hinney A. Eating disorders: the current status of molecular genetic research. Eur Child Adolesc Psychiatry 2010;19:211-226.
7. Lohoff F. Overview of the genetics of major depressive disorder. Curr Psychiatry Rep 2010;12:539-546.
8. Raizen DM, Wu MN. Genome-wide association studies of sleep disorders. Chest 2011;139:446-452.
9. Renz H, von Mutius E, Brandtzaeg P, et al. Gene-environment interactions in chronic inflammatory disease. Nat Immunol 2011;12:273-277. This review article provides important consideration of the role played by gut flora in the interaction between the environment and genetic background of the organism.
10. Gordon JI, Klaenhammer TR. A rendezvous with our microbes. Proc Natl Acad Sci USA 2011;108(Supplement 1):4513-4515.
11. Sekirov I, Russell SL, Antunes LCM, Finlay BB. Gut microbiota in health and disease. Physiol Rev 2010;90:859-904.
12. Reyes A, Haynes M, Hanson N, et al. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 2010;466:334-338. This report shows that bacterial but not viral species of the gut microbiome are shared between family members.
13. Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature 2011;473:174-180. This study provides a background for classification of humans according their gut bacteria into three major types. Furthermore, some bacterial genes represented as modules according to their functions were significantly associated with various human characteristic including BMI, sex and age.
14. Li W, Dowd SE, Scurlock B, et al. Memory and learning behavior in mice is temporally associated with diet-induced alterations in gut bacteria. Physiol Behav 2009;96:557-567.
15. Gareau MG, Wine E, Rodrigues DM, et al. Bacterial infection causes stress-induced memory dysfunction in mice. Gut 2011;60:307-317. This study showed that some behavioral phenotypes including memory impairment are associated with modulation of the gut flora and can be revealed only under stress conditions.
16. Gonzalez A, Stombaugh J, Lozupone C, et al. The mind-body-microbial continuum. Dialogues Clin Neurosci 2011;13:55-62. This review provides the evidence that links gut microbiome with some brain functions and neuropsychiatric disorders.
17. Murphy EF, Cotter PD, Healy S, et al. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 2010;59:1635-1642.
18. Lee YK, Mazmanian SK. Has the microbiota played a critical role in the evolution of the adaptive immune system? Science 2010;330:1768-1773.
19. Bouskra D, Brezillon C, Berard M, et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 2008;456:507-510. (Pubitemid 352759006)
20. Fetissov SO, Hamze Sinno M, Coeffier M, et al. Autoantibodies against appetite-regulating peptide hormones and neuropeptides: putative modulation by gut microflora. Nutrition 2008;24:348-359.
21. Oldstone MB. Molecular mimicry, microbial infection, and autoimmune disease: evolution of the concept. Curr Top Microbiol Immunol 2005;296:1-1 7. (Pubitemid 41667258)
22. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009;9:799-809.
23. Hamze Sinno M, Coquerel Q, Boukhettala N, et al. Chemotherapy-induced anorexia is accompanied by activation of brain pathways signaling dehydration. Physiol Behav 2010;101:639-648.
24. Coquerel Q, Hamze Sinno M, Boukhettala N, et al. Intestinal inflammation influences a-MSH reactive autoantibodies: relevance to food intake and body weight. Psychoneuroendocrinology 2011 (in press). This work provides initial evidence linking intestinal inflammation to the production of neuropeptide-reactive autoantibodies and shows that changes in plasma levels of autoantibodies reactive with a-MSH can participate in the body weight control relevant to the pathophysiology of anorexia nervosa.
25. Winer DA, Winer S, Shen L, et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med 2011;17:610-617. This study provides the evidence of the role of immunoglobulin response in insulin resistance and obesity. Particularly, the link between high fat diet and systemic IgG response is shown and some autoAbs as a part of this response were identified as interfering with adipocytes functioning.
26. Hamze Sinno M, Do Rego JC, Coeffier M, et al. Regulation of feeding and anxiety by a-MSH reactive autoantibodies. Psychoneuroendocrinology 2009;34:140-149.
27. Kastin AJ, Akerstrom V. Orexin A but not orexin B rapidly enters brain from blood by simple diffusion. J Pharmacol Exp Ther 1999;289:219-223. (Pubitemid 29156032)
28. Kastin AJ, Akerstrom V. Nonsaturable entry of neuropeptide Y into brain. Am J Physiol 1999;276(3 Pt 1):E479-E482. (Pubitemid 29157402)
29. Wilson JF, Anderson S, Snook G, Llewellyn KD. Quantification of the permeability of the blood-CSF barrier to alpha-MSH in the rat. Peptides 1984;5:681-685. (Pubitemid 14058543)
30. Fu A, Hui EK-W, Lu JZ, et al. Neuroprotection in stroke in the mouse with intravenous erythropoietin: Trojan horse fusion protein. Brain Res 2011;1369:203-207. This study illustrates the potential role of immunoglobulin molecule as a vector for peptide delivery to the brain.
31. Karaiskos D, Mavragani CP, Sinno MH, et al. Psychopathological and personality features in primary Sjogren's syndrome: associations with autoantibodies to neuropeptides. Rheumatology (Oxford) 2010;49:1762-1769. The extensive psychological characteristics of not only patients with this autoimmune disease but also healthy controls revealed significant associations of personality traits with plasma levels of neuropeptide autoAbs.
32. Fetissov SO, Harro J, Jaanisk M, et al. Autoantibodies against neuropeptides are associated with psychological traits in eating disorders. Proc Natl Acad Sci USA 2005;102:14865-14870. (Pubitemid 41457147)
33. Kaye WH, Fudge JL, Paulus M. New insights into symptoms and neurocircuit function of anorexia nervosa. Nat Rev Neurosci 2009;10:573-584.
34. Fetissov SO, Meguid MM. On dopamine, D2 receptor, and Taq1A polymorphism in obesity and anorexia. Nutrition 2009;25:132-133.
35. Cone RD. Anatomy and regulation of the central melanocortin system. Nat Neurosci 2005;8:571-578. (Pubitemid 40594196)
36. Fetissov SO, Hallman J, Oreland L, et al. Autoantibodies against a-MSH, ACTH, and LHRH in anorexia and bulimia nervosa patients. Proc Natl Acad Sci USA 2002;99:17155-17160. (Pubitemid 36034114)
37. Fetissov SO, Dechelotte P. The putative role of neuropeptide autoantibodies in anorexia nervosa. Curr Opin Clin Nutr Metab Care 2008;11:428-434.
38. Fetissov SO, Hamze Sinno M, Coquerel Q, et al. Emerging role of autoantibodies against appetite-regulating neuropeptides in eating disorders. Nutrition 2008;24:854-859.
39. Fetissov SO, Coquerel Q, Hamze Sinno M, et al., editors. Changes of affinity of autoantibodies against a-melanocyte-stimulating hormone are involved in the mechanisms of anorexia nervosa and bulimia. In: 9th World Congress of Biological Psychiatry; 28 June 2009; Paris, France.
40. Fetissov SO, Dechelotte P, Hamze Sinno M, Gilbert D. Method of diagnostic of neuropsychiatric diseases, eating disorders or metabolic diseases. France. 2008. WO2008040882.
41. Gareau MG, Silva MA, Perdue MH. Pathophysiological mechanisms of stressinduced intestinal damage. Curr Mol Med 2008;8:274-281. (Pubitemid 351982531)
42. Walsh NP, Gleeson M, Pyne DB, et al. Position statement. Part two: Maintaining immune health. Exerc Immunol Rev 2011;17:64-103.
43. Bailey MT, Dowd SE, Galley JD, et al. Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation. Brain Behav Immun 2011;25:397-407. This work provides experimental evidence on how psychological stress affects composition of gut microbiome.
44. Chuang JC, Zigman JM. Ghrelin's roles in stress, mood, and anxiety regulation. Int J Pept 2010;2010. pii:460549.
45. Yi C-X, Heppner K, Tschop MH. Ghrelin in eating disorders. Mol Cell Endocrinol 2011 (in press).
46. Terashi M, Asakawa A, Harada T, et al. Ghrelin reactive autoantibodies in restrictive anorexia nervosa. Nutrition 2011;27:407-413. This study supports a mechanism of ghrelin resistance in anorexia nervosa implicating ghrelin-reactive autoAbs. Such mechanism might be relevant to the general endocrine phenomenon of hormonal resistance.
47. Skinner C, Lin S-J. Effects of calorie restriction on lifespan of microorganisms. Appl Microbiol Biotechnol 2010;88:817-828.
48. Greiner T, Backhed F. Effects of the gut microbiota on obesity and glucose homeostasis. Trends Endocrinol Metab 2011;22:117-123.
49. Armougom F, Henry M, Vialettes B, et al. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and methanogens in anorexic patients. PLoS One 2009;4:e7125.
50. Vincenzi B, O'Toole J, Lask B. PANDAS and anorexia nervosa: a spotters' guide - suggestions for medical assessment. Eur Eat Disord Rev 2010;18:116-123.
51. Khoruts A, Sadowsky MJ. Therapeutic transplantation of the distal gut microbiota. Mucosal Immunol 2010;4:4-7. The existing experience of gut microbiota transplantation is very limited, but indicates an enormous therapeutic potential of commensal bacteria transfer in a variety of diseases.
52. Ochoa-Reparaz J, Mielcarz DW, Ditrio LE, et al. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J Immunol 2009;183:6041-6050.
53. Serino M, Luche E, Chabo C, et al. Intestinal microflora and metabolic diseases. Diabetes Metab 2009;35:262-272.
54. Nestler EJ, Hyman SE. Animal models of neuropsychiatric disorders. Nat Neurosci 2010;13:1161-1169.
55. Garcia FD, Coquerel Q, Kiive E, et al. Autoantibodies reacting with vasopressin and oxytocin in relation to cortisol secretion in mild and moderate depression. Prog Neuropsychopharmacol Biol Psychiatry 2010;35:118-125. This article provides the most recent data on how neuropeptide-reactive autoAbs might be involved in the pathophysiology of depression.
56. Maes M, Kubera M, Leunis JC. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett 2008;29:117-124.
57. Zheng S, Yu M, Lu X, et al. Urinary metabonomic study on biochemical changes in chronic unpredictable mild stress model of depression. Clin Chim Acta 2011;411:204-209.
58. Messaoudi M, Lalonde R, Violle N, et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr 2011;105:755-764.
59. Desbonnet L, Garrett L, Clarke G, et al. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 2010;170:1179-1188.
60. Chemelli RM, Willie JT, Sinton CM, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999;98:437-451. (Pubitemid 29402482)
61. Nishino S, Sagawa Y. The Neurochemistry of awakening: findings from sleep disorder narcolepsy. Int Rev Neurobiol 2010;93:229-255.
62. Fontana A, Gast H, Reith W, et al. Narcolepsy: autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss? Brain 2010;133(Pt 5):1300-1311.
63. Kornum BR, Kawashima M, Faraco J, et al. Common variants in P2RY11 are associated with narcolepsy. Nat Genet 2011;43:66-71.
64. Deloumeau A, Bayard S, Coquerel Q, et al. Increased immune complexes of hypocretin autoantibodies in narcolepsy. PLoS One 2010;5:e13320.
65. Dauvilliers Y, Montplaisir J, Cochen V, et al. Post-H1N1 narcolepsy-cataplexy. Sleep 2011;33:1428-1430.